Conceptulised by Lowe Lintas, the new campaign creatively brings the "fast action" benefit of Cipladine to life through a series of films
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
MANEUVER met all five key secondary endpoints, with statistically significant and clinically meaningful improvements in pain, stiffness, range of motion, physical function, and decrease in tumor volume
The initiative was announced at World Hypertension Congress, Chennai
During the quarter, US formulations revenue increased by 13.5 per cent YoY to Rs. 4,072 crore
EBITDA before special items decreases to €4.08 billion (7.4%)
Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease
Delivers robust earnings performance, successfully navigating a dynamic environment
Nadda noted that on the basis of economic caste census, 50 crore people were brought under this scheme
Approval based on AEGEAN Phase III trial results which showed a 32% reduction in the risk of recurrence, progression or death vs. neoadjuvant chemotherapy alone
Subscribe To Our Newsletter & Stay Updated
